Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session24/7 Wall Street • 08/21/26
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?The Motley Fool • 07/23/26
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared DamageSeeking Alpha • 07/21/26
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?The Motley Fool • 07/12/26
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBCCNBC • 06/16/26